🚨Very excited to see our work with Prof Claire Roddie out in @bloodjournal.bsky.social

CAR-T has revolutionized treatment for B-ALL, but what’s next? We discuss innovations, challenges, and the road ahead.

🔗 ashpublications.org/blood/articl...
#Leukemia #CARTcell #Hematology

Bye bye, bispecific?

Check out our commentary on the development of a CD19/BCMA dual targeting CAR-T for non-Hodgkin Lymphoma led by Bachiller et al.

Co-transduction for the win! Link below ⬇️ for free access authors.elsevier.com/a/1kIWB5QliS...

Amazing presentation by Camelia Benlabiod (@beth_psaila / Caroline Marty lab) on the biology of calreticulin driven myelofibrosis in an immunocompetent mouse model #ASH24 #MPNsm

Looking forward to presenting our result and discussing all about CAR-T cell therapy for mutated calreticulin myelofibrosis #ASH24 Do join!

Very eloquent presentation by Antonio Romera from @bethpsaila.bsky.social lab on megakaryocyte biology and ability to take on DNA damage! Fantastic work #ASH24

You can hear all about it on Monday at 14:45.

Very honoured to receive the ASH-BSH abstract achievement award

The result of the tremendous work by so many talented people who I had the privilege to work with
Zoe Wong, Isaac Gannon, @bethpsaila.bsky.social, Claire Roddie, Martin Pule and many more

#ASH24

Very pleased to present the results of a UK wide collaborative study on real world efficacy and safety of Momelotininb
- >60% anaemia responses at 6 months
-G1-2 peripheral neuropathy (15%)
-unexpected thrombocytosis (?hepcidin dysregulation due to AVCR1 inhibition)
#ASH24 @bethpsaila.bsky.social

Attending #ASH24 and missing my baby boy. At least I can get him on my cup of coffee

Off to #ASH24. Books/music/movies all ready for 12h of economy flight 💪